Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

UK Government Sets Recommendations for Sugar Reduction in Food Industry



The hope is that these sugar limits will help young people achieve a five percent reduction in their sugar intake in the next year, with a total 20 percent reduction in the next three years.

Share this!

March 31, 2017 | by Sarah Hand, M.Sc.

The UK government agency, Public Health England (PHE) has released voluntary guidelines aimed at reducing children’s sugar intake by the year 2020. The hope is that these sugar limits will help young people achieve a five percent reduction in their sugar intake in the next year, with a total 20 percent reduction in the next three years.

The recommended sugar limits will affect nine different categories of food, including biscuits, cereals, chocolate and ice cream, which have been shown to contribute most to sugar intake. The PHE also stipulates that the reduction in sugar should not be compensated for by an increase in saturated fat, and the government body is also looking for reduced calorie products.

According to Alison Cox, Cancer Research UK’s Director for Cancer Prevention, excess sugar consumption has been associated with an increased risk of obesity. In turn, obesity can increase a person’s risk of developing cancer as they age.

“Without action, the problem is only going to get worse, so it’s vital this new program works towards the goal of slashing the amount of sugar hidden in our food,” said Cox. “But this won’t happen unless the food industry acts now to meet these targets.”

In addition to recommending that the food industry lower sugar levels in products – especially those aimed at children – PHE says portion sizes should be cut down. They also recommend that consumers be encouraged to buy lower sugar/no added sugar food products.

“If industry can’t make this work, the NHS will struggle to deal with the obesity crisis we’re hurtling towards,” said Cox. “But this doesn’t have to be the case and we can’t afford to get this wrong. We hope to see companies cutting down on sugar and portion sizes over the coming years to play their part in improving our health.”

According to the PHE guidance document, overconsumption of sugar in the UK has contributed to obesity, tooth decay and other health problems. Along with leading to poorer health outcomes for citizens, excessive sugar consumption also places a substantial economic burden on the NHS.

“Overweight and obese children are likely to carry this health problem into adulthood, increasing their risk of type 2 diabetes, heart disease and some cancers,” said PHE’s chief nutritionist, Dr. Alison Tedstone. “Levels of obesity are higher in children from deprived backgrounds. Tackling the amount of sugar we eat is not just a healthy thing to do, but an issue of inequality for many families.”

Keywords:  Added Sugars, Food Industry, Obesity


Share this with your colleagues!

Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News

Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News

Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


One Patient’s Perspective on Clinical Trials


Planning and Conducting Trials of the Latest Immunotherapies

ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation

Medical Devices: Reviewing Regulatory Changes in the US and EU

Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials

Copyright © 2016-2017 Honeycomb Worldwide Inc.